Abattis Bioceuticals Corp. announced the additions of Kent McParland and Cedric Wilson to the Board of Directors. Mr. McParland and Mr. Wilson replace Cameron Paddock and Rene David who have left Abattis to concentrate on other ventures. Mr. McParland is a Chartered Professional Accountant experienced in multiple industries and geographical locations. As the company's Chief Financial Officer and Chief Operating Officer, Mr. McParland adds considerable financial depth to the Board as the company continues to grow rapidly within the Cannabis space. Mr. Wilson has over 30 years of financial services experience. In addition to working for a US Fortune 250 insurance company, Mr. Wilson is a serial entrepreneur, managing companies involved in a wide variety of industries ranging from real estate to food and beverage. Mr. Wilson has served as a director of several private and publicly listed companies, including a TSX senior listed company.